HIV & AIDS

Single dose of antibodies can knock out HIV in newborns

A single dose of an antibody-based treatment can prevent HIV transmission from mother to baby, new nonhuman primate research suggests for the first time. The findings are being published in the journal Nature Communications.

HIV & AIDS

Nurses can help manage drug interactions in HIV/Hep C treatment

(HealthDay)—Drug interactions between antiretroviral therapy (ART) and direct-acting antivirals (DAAs) pose a clinical challenge in patients with HIV/hepatitis C virus (HCV) coinfection, according to an article published ...

HIV & AIDS

Antiretroviral HIV medication attenuates liver fibrosis

Scientists from Valencia University (UV) have discovered that Rilpivirine, an antiretroviral drug used for treating HIV, has beneficial effects on chronic liver diseases. The finding opens a path to identify new therapies ...

HIV & AIDS

AIDS deaths down a third since 2010: UN

HIV-related deaths last year fell to around 770,000—some 33 percent lower than in 2010—the United Nations said Tuesday, but warned that global efforts to eradicate the disease were stalling as funding dries up.

HIV & AIDS

Naltrexone implant helps HIV patients prevent opioid relapse

(HealthDay)—Slow-release implantable naltrexone is associated with better outcomes than the oral drug for HIV-positive patients with an opioid addiction, according to a study published in the April issue of The Lancet HIV.

HIV & AIDS

HIV latency differs across tissues in the body

Mechanisms that govern HIV transcription and latency differ in the gut and blood, according to a study published November 15 in the open-access journal PLOS Pathogens by Steven Yukl of San Francisco Veterans Affairs Medical ...

page 1 from 19